|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||39.77 - 39.77|
|52-week range||31.55 - 49.86|
|Beta (5Y monthly)||0.97|
|PE ratio (TTM)||23.67|
|Forward dividend & yield||1.21 (3.05%)|
|Ex-dividend date||17 May 2023|
|1y target est||N/A|
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, announces the successful completion of its change of legal form from a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA) into a German stock corporation (Aktiengesellschaft, AG) as of November 30, 2023. With this important milestone, Fresenius Medical Care is opening a new chapter in the history of the Company with a simplified corporate governance structure tha
What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Fresenius Medical (FMS) wins legal dispute against the U.S. government. Both revenues and operating income will benefit from the settlement agreement.